| Number | Authors | Year | Age (years) | GP | Symptom | Location | Tumor size | Operation | Histological subtype | Postoperative therapy | Recurrence | Treatment of recurrence | Next treatment | Follow-up |
| 1 | Fujii et al. | 1977 | 51 | P2 | Bleeding | Corpus | cm | ATH+BSO | Undifferentiated, nonmyxoid type | RT | | | | NED, 3 M (before 1 year) | 2 | Veliath et al. | 1978 | 59 | G4P4 | Bleeding | Cervix | cm | ATH+BSO | Round cell | | Vaginal nodule, 1 M after operation | Excision | RT | N/A | 3 | Obafunwa and Uguru | 1990 | 45 | P8 | Bleeding | Cervix | Mass protruding from the cervix to the vagina | The mass excised, the cervix marsupialised | Pleomorphic | No | Recurrence, 6 M | Conservative | Extensively excised | Not reported in hospital | 4 | Katabuchi et al. | 1990 | 54 | G3P3 | Tumor | Left sacrouterine ligament | 8000 g | Resection of the tumor, ATH+BSO | Myxoid | No | Recurrence, 4 M | Tumor resection, CT, RT, immunotherapy | Partial tumor resection, colostomy, uretero- | DOD, 2Y2M | 5 | Schmidt and Doroszewski | 1996 | 78 | G2P2 | Tumor | Corpus | 13 cm | ATH+LtSO (previously Rt) | Myxoid and round cell | No | | | | Free of disease, 3 Y | 6 | Schneebauer et al. | 1996 | 67 | N/A | Tumor | Corpus | cm | ATH+BSO | Myxoid | No | | | | Free of disease, 3 Y | 7 | Takeuchi et al. | 2000 | 49 | Para 0 | Bleeding | Cervix | cm | ATH+BSO+PLN | Well differentiated | No | | | | Free of disease, 2 Y | 8 | Levine et al. | 2003 | 62 | G0P0 | Pain | Cervix, left sacrouterine ligament | 15 cm | ATH+BSO+PLN+PAN+O MT | Pleomorphic | No | Pelvic recurrence, 9 M | Multiple pelvic nodules excised, RT | | N/A | 9 | Karateke et al. | 2003 | 23 | G0P0 | Pain, tumor | Cervix | cm | Extirpation of the mass, local resection of tumor could not be achieved completely, and minimal residual disease was left in place unfortunately | Round and myxoid | CT | | | | Free of disease. 7 M (before 1 year) | 10 | Hong et al. | 2008 | 48 | N/A | Pain, bleeding, tumor | Corpus | cm | ATH+BSO | Myxoid | No | | | | Free of disease. 2 M (before 1 year) | 11 | McDonald et al. | 2011 | 49 | N/A | Tumor | Corpus | 10.5 cm | ATH+BSO | Pleomorphic | No | | | | Alive and well, 1 Y | 12 | McDonald et al. | 2011 | 70 | N/A | Tumor | Corpus | 10 cm | ATH+BSO | Myxoid | No | | | | Alive and well, 20 Y | 13 | McDonald et al. | 2011 | 58 | N/A | Bleeding, tumor | Corpus | 18 cm | ATH+BSO | Mixed pleomorphic and myxoid | No | | | | Alive and well, 2 Y | 14 | Fadare and Khabele | 2011 | 62 | N/A | Pain, tumor | Corpus | cm | ATH+BSO | Pleomorphic | RT | Recurrence, 2 M | Anterior abdominal nodule was resected, CT | | N/A | 15 | Arai et al. | 2014 | 77 | 3G3P | Tumor | Corpus | cm | ATH+BSO+OMT | Myxoid | No | | | | No rec, 6 M (before 1 year) | 16 | Schoolmeester et al. | 2016 | 70 | N/A | Dysuria and urinary retention | Corpus and cervix | cm | MRH+BSO+PLN | Pleomorphic | No | Numerous lung metastases, small and large intestine, a para-aortic lymph node | CT | | DOD, 3 M | 17 | Kiuchi et al. | 2018 | 55 | G6P3 | Tumor, bleeding | Corpus | cm | ATH+BSO | Well differentiated | No | | NED, 19 M | 18 | Lei et al. | 2021 | 77 | G4P4 | Bleeding | Uterine cavity | cm | LH+BSO | Dedifferentiated | N/A | | N/A | 19 | Hoshino et al. | 2023 | 58 | G4P2 | Tumor | Corpus | 4.8 cm | ATH+BSO | Well differentiated | No | | NED, 10 M, under observation |
|
|
G: gravidity; P: parity; N/A: not available, not applicable; MRH: modified radical hysterectomy; ATH: abdominal total hysterectomy; LH: laparoscopic hysterectomy; BSO: bilateral salpingo-oophorectomy; PLN: pelvic lymphadenectomy; PAN: para-aortic lymphadenectomy; OMT: omentectomy; meta: metastasis; RT: radiotherapy; CT: chemotherapy; NED: no evidence of disease; DOD: dead of disease. Italic texts: locations in recurrent or provable recurrent cases; incomplete operations; and undifferentiated, pleomorphic, or dedifferentiated in subtype. Bold texts: recurrent or provable recurrent cases.
|